23. Future Oncol. 2018 Jul 18. doi: 10.2217/fon-2018-0184. [Epub ahead of print]Tailoring breast cancer therapies to reduce mortality and improve quality oflife: San Antonio Breast Cancer Symposium 2017 (partÂ 2).Benson JR(1), Jatoi I(2).Author information: (1)Cambridge University NHS Foundation Trust, University of Cambridge and School of Medicine, Anglia Ruskin University, Cambridge, UK.(2)Division of Surgical Oncology, Dale H Dorn Chair in Surgery, University ofTexas Health Science Center, San Antonio, TX, USA.The 40th annual San Antonio Breast Cancer Symposium was convened in San Antonio, TX, USA on 5-9 December 2017. More than 7500 clinicians and scientists fromaround the world participated in the symposium which featured a range ofpresentations and keynote talks pertaining to breast cancer screening,prevention, loco-regional and systemic therapies. This two-part report highlightsa selection of important studies presented at this premier breast cancer eventwith part 1 focusing on dose-intense radiotherapy, perioperative endocrinetherapy, duration of bisphosphonates, immunotherapy, ovarian function suppressionand acupuncture. The second part of this report will discuss a range of topicsrelated to de-escalation of loco-regional therapies, the significance of completepathological response, older patients and CDK 4/6 inhibitors, circulating tumorcells and plasma DNA as a tumor marker.DOI: 10.2217/fon-2018-0184 PMID: 30019940 